Synlogic Inc (SYBX)
1.79
-0.04
(-2.19%)
USD |
NASDAQ |
May 10, 16:00
1.79
0.00 (0.00%)
After-Hours: 20:00
Synlogic SG&A Expense (Quarterly): 3.27M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.27M |
September 30, 2023 | 3.40M |
June 30, 2023 | 3.924M |
March 31, 2023 | 3.967M |
December 31, 2022 | 3.77M |
September 30, 2022 | 4.402M |
June 30, 2022 | 4.112M |
March 31, 2022 | 4.271M |
December 31, 2021 | 3.864M |
September 30, 2021 | 3.616M |
June 30, 2021 | 4.061M |
March 31, 2021 | 3.851M |
December 31, 2020 | 3.287M |
September 30, 2020 | 2.956M |
June 30, 2020 | 3.473M |
March 31, 2020 | 3.821M |
December 31, 2019 | 3.456M |
September 30, 2019 | 3.879M |
June 30, 2019 | 3.742M |
Date | Value |
---|---|
March 31, 2019 | 3.651M |
December 31, 2018 | 3.952M |
September 30, 2018 | 3.401M |
June 30, 2018 | 4.734M |
March 31, 2018 | 3.629M |
December 31, 2017 | 4.293M |
September 30, 2017 | 3.231M |
June 30, 2017 | 4.232M |
March 31, 2017 | 2.264M |
December 31, 2016 | 1.999M |
September 30, 2016 | 1.94M |
June 30, 2016 | 2.049M |
March 31, 2016 | 2.13M |
December 31, 2015 | 2.462M |
September 30, 2015 | 1.556M |
June 30, 2015 | 1.185M |
March 31, 2015 | 0.877M |
December 31, 2014 | 0.868M |
September 30, 2014 | 0.715M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
2.956M
Minimum
Sep 2020
4.402M
Maximum
Sep 2022
3.743M
Average
3.821M
Median
Mar 2020
SG&A Expense (Quarterly) Benchmarks
BioXcel Therapeutics Inc | 9.603M |
Inotiv Inc | 25.28M |
IGM Biosciences Inc | 11.58M |
Humacyte Inc | 6.002M |
Moderna Inc | 274.00M |